Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (121-130 of 260) with videos related to

Pageof 26
Sort By:
Circulation. Arrhythmia and Electrophysiology|March 4, 2014
Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclearBinu Philips, Srinivasa Madhavan, Cynthia A James, et al.
Journal of the American College of Cardiology|January 14, 2012
Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathyRyan J Tedford, Cynthia James, Daniel P Judge, et al.
Circulation. Arrhythmia and Electrophysiology|February 18, 2018
Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyGabriela M Orgeron, Anneline Te Riele, Crystal Tichnell, et al.
JCI Insight|May 13, 2016
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathyStephen P Chelko, Angeliki Asimaki, Peter Andersen, et al.
Heart Rhythm|December 23, 2014
Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathyBinu Philips, Anneline S J M te Riele, Abhishek Sawant, et al.
Circulation. Genomic and Precision Medicine|April 22, 2026
Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate PrescriptionsNatalie Telis, Douglas Stoller, Christopher N Chapman, et al.
Implementation Science Communications|April 28, 2022
A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populationsCaitlin G Allen, Daniel P Judge, Elissa Levin, et al.
Journal of the American Heart Association|June 8, 2017
Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and ComplicationsGabriela M Orgeron, Cynthia A James, Anneline Te Riele, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 13, 2017
Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosisEmily E Brown, Yi Zhen Joan Lee, Marc K Halushka, et al.
American Journal of Human Genetics|June 15, 2006
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathyMark M Awad, Darshan Dalal, Eunpi Cho, et al.
Pageof 26

Showing results (121-130 of 260) with videos related to

Sort By:
Pageof 26
Circulation. Arrhythmia and Electrophysiology|March 4, 2014
Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclearBinu Philips, Srinivasa Madhavan, Cynthia A James, et al.
Journal of the American College of Cardiology|January 14, 2012
Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathyRyan J Tedford, Cynthia James, Daniel P Judge, et al.
Circulation. Arrhythmia and Electrophysiology|February 18, 2018
Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyGabriela M Orgeron, Anneline Te Riele, Crystal Tichnell, et al.
JCI Insight|May 13, 2016
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathyStephen P Chelko, Angeliki Asimaki, Peter Andersen, et al.
Heart Rhythm|December 23, 2014
Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathyBinu Philips, Anneline S J M te Riele, Abhishek Sawant, et al.
Circulation. Genomic and Precision Medicine|April 22, 2026
Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate PrescriptionsNatalie Telis, Douglas Stoller, Christopher N Chapman, et al.
Implementation Science Communications|April 28, 2022
A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populationsCaitlin G Allen, Daniel P Judge, Elissa Levin, et al.
Journal of the American Heart Association|June 8, 2017
Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and ComplicationsGabriela M Orgeron, Cynthia A James, Anneline Te Riele, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 13, 2017
Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosisEmily E Brown, Yi Zhen Joan Lee, Marc K Halushka, et al.
American Journal of Human Genetics|June 15, 2006
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathyMark M Awad, Darshan Dalal, Eunpi Cho, et al.
Pageof 26